In the "activated" state, the CTL recognizes MHC-I-like molecules on the cancer cell surface and kills the target cells via granule cytosolization (granzyme A and B) and necrosis and apoptosis triggered by death ligands in the presence of chemokines. The gene discussed is GZMA; the disease is cancer.